The DOI matches its Crossref record; 203 of the 203 references it cites were found in a registry or an index.
Anti-HIV Drug Discovery and Development: Current Innovations and Future Trends: Miniperspective
Open accessAbstract
The early effectiveness of combinatorial antiretroviral therapy (cART) in the treatment of HIV infection has been compromised to some extent by rapid development of multidrug-resistant HIV strains, poor bioavailability, and cumulative toxicities, and so there is a need for alternative strategies of antiretroviral drug discovery and additional therapeutic agents with novel action modes or targets. From this perspective, we first review current strategies of antiretroviral drug discovery and optimization, with the aid of selected examples from the recent literature. We highlight the development of phosphate ester-based prodrugs as a means to improve the aqueous solubility of HIV inhibitors, and the introduction of the substrate envelope hypothesis as a new approach for overcoming HIV drug resistance. Finally, we discuss future directions for research, including opportunities for exploitation of novel antiretroviral targets, and the strategy of activation of latent HIV reservoirs as a means to eradicate the virus.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–203 of 203
In silico screening of HIV-1 non-nucleoside reverse transcriptase and protease inhibitors
Leitão, A., Andricopulo, A. D., & Montanari, C. A. (2007) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2007.08.017 · Cited by 9
Qu, X., Ying, H., Wang, X., Kong, C., Zhou, X., Wang, P., & Zhu, H. (2013) · Current HIV Research · doi:10.2174/157016213804999249 · Cited by 8
Identification of a novel type of small molecule inhibitor against HIV-1
Kim, B., Park, J. A., Kim, M.-J., Kim, S. H., Yu, K. L., & You, J. C. (2015) · BMB Reports · doi:10.5483/bmbrep.2015.48.2.239 · Cited by 6
Cited by
Recent Progress in the Development of HIV-1 Protease Inhibitors for the Treatment of HIV/AIDS
Ghosh, A. K., Osswald, H. L., & Prato, G. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01697 · Cited by 419
An overview of molecular hybrids in drug discovery
Bérubé, G. (2016) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2016.1135125 · Cited by 338
Metadata
- Authors
- Zhan, P., Pannecouque, C., De Clercq, E., & Liu, X.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2015-11-05
- Volume
- 59
- Issue
- 7
- Pages
- 2849-2878
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W2337272231
- Cited by
- 303
- References
- 203
- FWCI
- 20.72
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.